Nan Zhou is a PhD researcher in the EPSRC Centre for Doctoral Training in Aerosol Science at the University of Bristol, bridging aerosol science and respiratory pharmacoepidemiology.
He leads a pharmacoepidemiological study using the Clinical Practice Research Datalink (CPRD) to investigate switching between pressurised metered-dose inhalers and dry powder inhalers in people with asthma.
He particularly enjoys the challenge of turning complex, routinely collected healthcare data into clinically meaningful evidence and collaborating with epidemiologists, clinicians and aerosol scientists.
A major achievement was the selection of his research for a plenary presentation at Drug Delivery to the Lungs 2025, where he presented his findings to an international audience of researchers, clinicians and industry specialists. His aim is to generate evidence supporting safer, more patient-centred inhaler switching, helping the UK National Health Service reduce its carbon footprint without compromising asthma control.
